# LITHIUM CARBONATE
> **ANDA091544** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS · Approved 2010-12-27
## Drug
- **FDA Application Number:** ANDA091544
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LITHIUM CARBONATE
- **Generic name:** LITHIUM CARBONATE
- **Active ingredients:** LITHIUM CARBONATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2010-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091544)
---
*MORVS · CC0 1.0*